- Home
- VCIG vs PPBT Comparison
VCIG vs PPBT Comparison
Compare VCIG & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VCIG | PPBT |
|---|---|---|
| Founded | 2013 | 2010 |
| Country | Malaysia | Israel |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9M | 2.9M |
| IPO Year | 2022 | 2014 |
Fundamental Metrics
Financial Performance| Metric | VCIG | PPBT |
|---|---|---|
| Price | $4.80 | $1.78 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $30.00 |
| AVG Volume (30 Days) | ★ 5.6M | 124.7K |
| Earning Date | 05-08-2026 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $1.81 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.20 | $0.41 |
| 52 Week High | $23.40 | $5.18 |
Technical Indicators
Market Signals| Indicator | VCIG | PPBT |
|---|---|---|
| Relative Strength Index (RSI) | 50.91 | 27.88 |
| Support Level | $0.70 | $0.57 |
| Resistance Level | $11.58 | $3.09 |
| Average True Range (ATR) | 1.76 | 0.24 |
| MACD | -0.35 | -0.09 |
| Stochastic Oscillator | 8.40 | 16.77 |
Price Performance
Historical ComparisonAbout VCIG VCI Global Limited
VCI Global Ltd is a holding company. The principal activities of the Company and its subsidiaries are the provision of business Strategy consultancy and technology development. The firm organized its consulting services into three main segments: Business Strategy Consultancy; Technology development, solutions and consultancy; and Others. It derives the majority of its revenue from the Business Strategy Consultancy segment, which focuses on listing solutions, investor relations, and boardroom strategies consultancy.
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage biotechnology company focused on the development and commercialization of pharmaceuticals. It currently have a preclinical tri-specific antibodies platform, CAPTN-3, with its therapeutic candidates, IM1240 and IM1305, and two other oncology therapeutic candidates that are in the clinical trial phase, CM24 and NT219, neither of which has been approved for marketing and are not being sold, marketed, or commercialized.